[PDF][PDF] The Efficacy of Renal Denervation in Treating Resistant Hypertension: A Systematic Review

GA Azeez, M Thirunagari, N Fatima, A Anand… - Cureus, 2024 - cureus.com
Resistant hypertension is blood pressure (BP) that is persistently above target in spite of the
maximally tolerated usage of at least three anti-hypertensives simultaneously. The …

Renal Denervation: Antihypertensive Therapy or Gizmo Idolatry?

FH Messerli - Journal of the American College of Cardiology, 2025 - jacc.org
GUIDELINES Most national and international hypertension guidelines were published
before FDA approval of RDN. They either sidestep the topic of RDN or approach it carefully …

2024 Latin American Society of Hypertension guidelines on the management of arterial hypertension and related comorbidities in Latin America

R Sánchez, A Coca, DIM de Salazar… - Journal of …, 2025 - journals.lww.com
Hypertension is responsible for more than two million deaths due to cardiovascular disease
annually in Latin America (LATAM), of which one million occurs before 70 years of age …

Spectrum of Hyperaldosteronism, Opportunities for Diagnosis

J Zeman, K Pacak, GJ Acosta, HK Ghayee… - Annals of Internal …, 2024 - acpjournals.org
Primary aldosteronism (PA) is a common cause of secondary hypertension. It is
characterized by renin-independent overproduction of aldosterone by the adrenal glands …

Aldosterone-to-Renin Ratio as a Diagnostic and Prognostic Marker in Resistant Hypertension: Insights from a Retrospective Observational Study on Age, Hormonal …

AK Choudhary, A Munir, JS George, H Selvaraj… - Asian Journal of …, 2024 - ajprd.com
Resistant hypertension (RH) presents a significant clinical challenge, often requiring multi-
faceted management strategies. This study aimed to evaluate the utility of the Aldosterone-to …